Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Generic Companies Race To Withdraw ANDAs
08 Jul 2019
•
By
Derrick Gingery
Industry consolidation may be a reason ANDA withdrawals have increased during GDUFA II.
After 606 ANDAs were removed in FY 2018, another 252 have been pulled in FY 2019, many of them approved applications. • Source: Shutterstock
More from Generics
More from Biosimilars & Generics